查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433614

體外診斷全球市場規模、佔有率、趨勢分析報告：按產品、測試地點、最終用途、應用、技術、地區和細分市場進行預測（2024-2030）

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End-use, By Application, By Technology, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

體外診斷市場成長與趨勢：

預計2030年，全球體外診斷市場規模將達到1,015.8億美元。不斷成長的老年人口、COVID-19 大流行以及診斷技術的進步正在推動普及，在預測期內複合年成長率為 4.4%。

攜帶性、準確性和成本效益的技術進步預計將成為具有高影響力的促進因素。 COVID-19 IVD 診斷的推出進一步加速了技術進步，加強了 PCR 等技術設備和耗材的採用。市場上的競爭對手擴大採用協議和合作夥伴策略來維持製造商和用戶的持續業務流。

這些協議也是政府實驗室嚴格價格控制策略的結果，降低了政府環境中的價格。例如，2021年4月，Seegene, Inc.的義大利子公司就供應715萬份SARS-CoV-2診斷檢測以及萃取試劑進行了1.0825億美元的公共採購競標，我收到了。 SARS-CoV-2診斷檢測主要旨在提供SARS-CoV-2診斷檢測和SARS-CoV-2萃取試劑，但增加了多方交易和供應鏈的複雜性。全球癌症和心血管疾病 (CVD) 的高盛行率預計將推動診斷創新，以促進早期診斷並滿足消費者不斷變化的需求。等離子 PCR 等新技術預計將在預測期內進入商業性市場，從而對現有產品的業務產生負面影響。

體外診斷市場報告亮點

  • 由於採用率和使用率不斷上升，分子診斷預計將從 2024 年到 2030 年以最快的複合年成長率成長。
  • 由於基因檢測需求的快速成長以及臨床需求未滿足的低收入和中等收入國家技術先進的診斷檢測的可用性不斷增加，試劑佔據了最大的市場佔有率。
  • 由於全球範圍內進行了大量的傳染病檢查，感染疾病應用佔據了最大的市場佔有率。
  • 由於對新技術的高需求、主要企業數量眾多、疾病盛行率高以及醫療基礎設施先進，2023 年的全球市場將由北美主導。

目錄

第1章體外診斷市場：調查方法與範圍

第2章體外診斷市場：市場定義

第3章體外診斷市場：執行摘要

  • 市場概況

第4章體外診斷市場：產品評估與趨勢分析

  • 細分儀表板
  • 體外診斷市場：產品波動分析（2023/2030）
  • 裝置
  • 試劑
  • 服務

第5章體外診斷市場：技術評估與趨勢分析

  • 細分儀表板
  • 體外診斷市場：技術變革分析（2023 年和 2030 年）
  • 免疫檢測
  • 血液學
  • 臨床化學
  • 分子診斷
  • 凝固
  • 微生物學
  • 其他

第6章體外診斷市場：應用估算與趨勢分析

  • 細分儀表板
  • 體外診斷市場：應用變化分析（2023/2030）
  • 感染疾病
  • 糖尿病
  • 腫瘤學/癌症
  • 心臟病學
  • 腎臟病學
  • 自體免疫疾病
  • 藥檢
  • 其他

第7章體外診斷市場：檢測地點的估計和趨勢分析

  • 細分儀表板
  • 體外診斷市場：測試地點變化分析（2023/2030）
  • 照護現場
  • 居家照護
  • 其他

第8章體外診斷市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 體外診斷市場：最終用途變化分析（2023 年和 2030 年）
  • 醫院
  • 實驗室
  • 居家照護
  • 其他

第9章體外診斷市場：區域估計與趨勢分析

  • 體外診斷市場佔有率：按地區（2023/2030）
  • 北美洲
    • 北美體外診斷市場估計與預測（2018-2030）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲體外診斷市場估計與預測（2018-2030）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
    • 俄羅斯
  • 亞太地區
    • 亞太地區體外診斷市場估計與預測（2018-2030）
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 新加坡
  • 拉丁美洲
    • 拉丁美洲體外診斷市場估計與預測（2018-2030）
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 中東和非洲體外診斷市場估算與預測（2018-2030）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第10章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 全球企業市場佔有率分析（2023）
  • 企業熱力圖分析
  • 策略規劃
    • 業務擴展
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • QIAGEN
    • BD
    • bioMerieux SA
    • F. Hoffmann-La Roche, Ltd.
    • QuidelOrtho Corporation
    • Abbott
    • Agilent Technologies, Inc.
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • Sysmex Corporation
    • Charles River Laboratories
    • Quest Diagnostics Incorporated
Product Code: 978-1-68038-080-4

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 101.58 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 4.4% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

  • Molecular diagnostics is anticipated to grow at the fastest CAGR from 2024 to 2030 owing to the rising adoption and usage rate
  • Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
  • The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
  • North America dominated the global market in 2023 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

Table of Contents

Chapter 1 In Vitro Diagnostics Market: Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
  • 1.12 List Of Abbreviations

Chapter 2 In Vitro Diagnostics Market: Market Definitions

Chapter 3 In Vitro Diagnostics Market: Executive Summary

  • 3.1 Market Summary

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030 (Volume Analysis)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests Sold)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, USD Million, 2023 & 2030 (Volume Analysis)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, USD Million, 2023 & 2030
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, USD Million, 2023 & 2030
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Home-care
    • 8.5.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2023 & 2030, USD Million
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.10. Russia
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.10.3. Competitive Insights
      • 9.3.10.4. Russis In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.8. Singapore
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.8.3. Competitive Insights
      • 9.4.8.4. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2023
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. QIAGEN
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. BD
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. bioMerieux SA
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. F. Hoffmann-La Roche, Ltd.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. QuidelOrtho Corporation
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Abbott
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Agilent Technologies, Inc.
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Siemens Healthineers AG
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Bio-Rad Laboratories, Inc.
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Danaher
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Sysmex Corporation
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. Charles River Laboratories
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Quest Diagnostics Incorporated
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million Number of instruments installed in thousands, Number of reagents sold in million
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 8 Global In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 14 North America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 24 Canada In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 26 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 27 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 28 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 29 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 30 Europe In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 31 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 32 UK In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 33 UK In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 34 UK In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 35 UK In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 36 UK In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 37 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 38 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 39 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 40 Germany America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 41 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 42 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 43 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 44 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 45 France In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 46 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 47 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 48 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 49 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 50 Spain In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 51 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 52 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 53 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 54 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 55 Italy In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 56 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 57 Russia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 58 Russia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 59 Russia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 60 Russia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 61 Russia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 66 Asia-Pacific In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 68 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 69 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 70 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 71 China In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 72 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 73 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 74 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 75 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 76 Japan In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 78 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 79 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 80 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 81 India In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 82 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 83 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 85 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 86 South Korea In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 88 Singapore In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 89 Singapore In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 90 Singapore In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 91 Singapore In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 92 Singapore In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 93 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 94 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 95 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 96 Australia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 97 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 98 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 99 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 100 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 101 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 102 Latin America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 103 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 104 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 105 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 106 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 107 Brazil In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 108 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 109 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 110 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 111 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 112 Mexico In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 113 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 114 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 115 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 116 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 117 Argentina In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 118 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 119 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 120 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 121 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 122 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 123 MEA In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 124 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 125 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 126 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 127 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 128 South Africa In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 129 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 130 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 131 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 132 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 133 UAE In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 134 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 135 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 136 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 137 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 138 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 139 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2023
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 In vitro diagnostic market driver impact
  • Fig. 13 Global population by age group, 2016 & 2027
  • Fig. 14 Global elderly population
  • Fig. 15 New cancer cases by year
  • Fig. 16 In vitro diagnostic market restraint impact
  • Fig. 17 Market entry strategy
  • Fig. 18 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 Consumer behavior analysis
  • Fig. 21 Strategy mapping
  • Fig. 22 IVD market: Product outlook and key takeaways
  • Fig. 23 IVD market: Products movement analysis
  • Fig. 24 Instruments market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands
  • Fig. 25 Reagents market estimates and forecast, 2018 - 2030 (USD Million), Number of reagents sold in millions
  • Fig. 26 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 IVD market: Technology outlook and key takeaways
  • Fig. 28 IVD Market: Technology movement analysis
  • Fig. 29 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 30 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Hematology market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 34 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 38 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 42 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Coagulation market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 46 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Microbiology market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 50 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 54 Instruments others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Reagents others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 IVD market: Application outlook and key takeaways
  • Fig. 58 IVD market: Application movement analysis
  • Fig. 59 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 IVD market: End-use outlook and key takeaways
  • Fig. 68 IVD treatment market: End-use movement analysis
  • Fig. 69 Hospitals market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 70 Laboratory market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 71 Home care market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 72 Other market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 73 IVD market: test location outlook and key takeaways
  • Fig. 74 IVD treatment market: Test location movement analysis
  • Fig. 75 Point-of-care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 IVD Market: Regional outlook and key takeaways
  • Fig. 79 IVD market: Regional movement analysis
  • Fig. 80 North America
  • Fig. 81 North America, SWOT
  • Fig. 82 North America. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 83 U.S. key country dynamics
  • Fig. 84 U.S. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 85 Canada key country dynamics
  • Fig. 86 Canada market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 87 Europe
  • Fig. 88 Europe, SWOT
  • Fig. 89 Europe market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 90 UK key country dynamics
  • Fig. 91 UK market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 92 Germany key country dynamics
  • Fig. 93 Germany market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 94 Spain key country dynamics
  • Fig. 95 Spain market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 96 France key country dynamics
  • Fig. 97 France market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 98 Italy key country dynamics
  • Fig. 99 Italy market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 100 Russia key country dynamics
  • Fig. 101 Russia market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 102 Denmark key country dynamics
  • Fig. 103 Denmark market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 104 Sweden key country dynamics
  • Fig. 105 Sweden market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 106 Norway key country dynamics
  • Fig. 107 Norway market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 108 Asia Pacific
  • Fig. 109 Asia Pacific, SWOT
  • Fig. 110 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 111 Japan key country dynamics
  • Fig. 112 Japan market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 113 China key country dynamics
  • Fig. 114 China. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 115 India key country dynamics
  • Fig. 116 India. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 117 South Korea key country dynamics
  • Fig. 118 South Korea market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 119 Singapore key country dynamics
  • Fig. 120 Singapore market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 121 Thailand key country dynamics
  • Fig. 122 Thailand market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 123 Australia key country dynamics
  • Fig. 124 Australia market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 125 Latin America
  • Fig. 126 Latin America, SWOT
  • Fig. 127 Latin America market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 128 Brazil key country dynamics
  • Fig. 129 Brazil market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 130 Mexico key country dynamics
  • Fig. 131 Mexico market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 132 Argentina key country dynamics
  • Fig. 133 Argentina market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 134 Middle East & Africa
  • Fig. 135 Middle East & Africa, SWOT
  • Fig. 136 MEA market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 137 South Africa key country dynamics
  • Fig. 138 South Africa market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 139 United Arab Emirates key country dynamics
  • Fig. 140 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 141 Saudi Arabia key country dynamics
  • Fig. 142 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 143 Ansoff matrix
  • Fig. 144 Competition categorization
  • Fig. 145 Company market share analysis, 2023
  • Fig. 146 Global mass spectrometry company market share analysis, 2023
  • Fig. 147 North America mass spectrometry company market share analysis, 2023
  • Fig. 148 Europe mass spectrometry company market share analysis, 2023
  • Fig. 149 Asia Pacific mass spectrometry company market share analysis, 2023
  • Fig. 150 Global immunoassay company market share analysis, 2023
  • Fig. 151 North America immunoassay company market share analysis, 2023
  • Fig. 152 Europe immunoassay company market share analysis, 2023
  • Fig. 153 Asia Pacific immunoassay company market share analysis, 2023
  • Fig. 154 Global PCR company market share analysis, 2023
  • Fig. 155 North America PCR company market share analysis, 2023
  • Fig. 156 Europe PCR company market share analysis, 2023
  • Fig. 157 Asia Pacific PCR company market share analysis, 2023
  • Fig. 158 Company market position analysis
  • Fig. 159 Company market position analysis
  • Fig. 160 Company market position analysis
  • Fig. 161 Company profiles
  • Fig. 162 Regional network map